Gutscheinbedingungen

**Gültig bis 06.07.2026 auf fremdsprachige Bücher online auf thalia.at, in der Thalia App ab einem Mindestbestellwert von 30€ und in allen Thalia Buchhandlungen in Österreich. In den Buchhandlungen nur gültig auf lagernde Ware. Einzelne Artikel können ausgeschlossen sein. Ausgenommen sind preisgebundene Artikel & eBooks. Pro Einkauf einmal einlösbar. Nur gültig gegen Vorlage oder im Onlineshop hinterlegter Bonuscard. Infos zur Einlösung in der Buchhandlung sind auf der Bonuscard-Vorteilspreisseite zu finden. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Einlösung bei Scan & Go-Bezahlung. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Versandkosten und Services.

  • Produktbild: The Advanced Handbook of Methods in Evidence Based Healthcare
  • Produktbild: The Advanced Handbook of Methods in Evidence Based Healthcare

The Advanced Handbook of Methods in Evidence Based Healthcare

229,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

28.12.2000

Herausgeber

Andrew J. Stevens + weitere

Verlag

O'Reilly

Seitenzahl

544

Maße (L/B/H)

26/18,3/3,3 cm

Gewicht

1270 g

Sprache

Englisch

ISBN

978-0-7619-6144-4

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

28.12.2000

Herausgeber

Verlag

O'Reilly

Seitenzahl

544

Maße (L/B/H)

26/18,3/3,3 cm

Gewicht

1270 g

Sprache

Englisch

ISBN

978-0-7619-6144-4

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: The Advanced Handbook of Methods in Evidence Based Healthcare
  • Produktbild: The Advanced Handbook of Methods in Evidence Based Healthcare
  • Introduction
    Methods in Evidence Based Healthcare and Health Technology Assessment - An Overview
    PART ONE: CLINICAL TRIALS
    Introduction - Richard J Lilford and Andrew Stevens
    Ethical Issues in the Design and Conduct of Randomized Controlled Trials - Richard J Lilford, Sarah Edwards, David Braunholtz, Jennifer Jackson, Jim Thornton and Jenny Hewison
    Ethics of Clinical Trials - Richard E Ashcroft
    Social, Cultural and Economic Factors
    Factors That Limit the Number, Progress and Quality of Randomized Controlled Trials - Sue Ross, Carl Counsell, William J Gillespie, Adrian Grant, Robin Prescrott, Ian Russell, Iain Colthart, Sandra Kiauka, Daphne Russell and Sue Shepard
    A Systematic Review
    Results of Clinical Trials and Systematic Reviews - Dianne O¿Connell, Paul P Glasziou, Suzanne Hill, Jasminka Sarunac, Julia Lowe and David Henry
    To Whom Do They Apply?
    The Placebo Effect - Rosemary Crow, Heather Gage, Sarah E Hampson, Jo Hart, Alan C Kimber and Hilary Thomas
    Methodological Process and Implications of a Structured Review
    PART TWO: OBSERVATIONAL AND QUALITATIVE METHODS
    Introduction - Ray Fitzpatrick
    Randomized and Non-Randomized Studies - Colin Sanderson, Martin McKee, Annie Britton, Nicholas Black, Klim McPherson and Chris Bain
    Threats to Internal and External Validity
    A Review of Observational, Quasi-Experimental and Randomized Study Designs for the Evaluation of the Effectiveness of Healthcare Interventions - Barnaby Reeves, Rachel MacLehose, Ian Harvey, Trevor Sheldon, Ian Russell and Andrew McLaren Spiers Black
    The Potential Use of Routine Data Sets in Health Technology Assessment - James Raftery, Andrew Stevens and Paul Roderick
    Using Routine Data to Complement and Enhance the Results of Randomized Controlled Trials - James Lewsey, Gordon Murray, Alastair H Leyland and Andrew Boddy
    Qualitative Methods in Health Technology Assessment - Elizabeth Murphy and Robert Dingwall
    PART THREE: MEASUREMENT OF BENEFIT AND COST
    Introduction - John Brazier
    Criteria for Assessing Patient-Based Outcome Measures for Use in Clinical Trials - Ray Fitzpatrick, Claire Davey, Martin Buxton and David Jones
    The Use of Health Status Measures in Economic Evaluation - John Brazier, Mark Deverill and Colin Green
    Collecting Resource Use Data for Costing in Clinical Trials - Katharine Johnstone, Martin Buxton, David Jones and Ray Fitzpatrick
    Eliciting Time Preferences for Health - John Cairns and Marjon van der Pol
    The Conduct and Design of Questionnaire Surveys in Healthcare Research - Elaine McColl, Ann Jacoby, Lois Thomas, Jennifer Soutter, Claire Bamford, Nick Steen, Roger Thomas, Emma Harvey, Andrew Garratt and John Bond
    PART FOUR: ANALYTICAL METHODS
    Introduction - Keith R Abrams
    Bayesian Methods - David Spiegelhalter, Jonathan Myles, David Jones and Keith Abrams
    Methods for Evaluating Organization or Area-Based Health Interventions - Martin Gulliford, Obioha C Ukoummunne, Susan Chinn, Jonathan Sterne, Peter Burney and Allan Donner
    Handling Uncertainty in Economic Evaluation - Andrew Briggs and Alastair Gray
    A Review of the Use of the Main Quality of Life Measures, and Sample Size Determination for Quality of Life Measures, Particularly in Cancer Trials - Michael Campbell, Steven A Julious, Sarah Walker, Steve George and David Machin
    Simultaneous Assessment of Quality of Life and Survival Data - Lucinda Billingham, Keith Abrams and David Jones
    PART FIVE: CONSENSUS, REVIEWS AND META-ANALYSIS
    Introduction - Andrew Stevens and Keith R Abrams
    Publication and Related Biases - Fuijan Song, Alison Eastwood, Simon Gilbody, Lelia Buley and Alex Sutton
    Meta-Analysis in Health Technology Assessment - Alexander Sutton, David Jones, Keith Abrams, Trevor Sheldon and Fujian Song
    Assessing the Quality of Reports of Randomized Trials Included in Meta-Analyses - David Moher, Terry Klassen, Alison Jones BäPham, Deborah Cook, Alejandro Jada, Peter Tugwell and Michael Moher
    Attitudes, Practice, Evidence and Guides
    Consensus Development Methods, and Their Use in Creating Clinical Guidelines - Nick Black, Maggie Murphy, Donna Lamping, Martin McKee, Colin Sanderson, Janet Askham and Theresa Marteau
    PART SIX: IDENTIFYING AND FILLING GAPS IN THE EVIDENCE
    Introduction - Andrew Stevens
    Identifying New Health Care Technologies - Glenn Robert, Andrew Stevens and John Gabbay
    Timing of Assessment of Fast-Changing Health Technologies - Graham Mowatt, Adrian Grant, D Jane Bower, John A Brebner, John Cairns and Lorna McKee
    Preliminary Economic Evaluation of Health Technologies - Gareth Harper, Joy Townsend and Martin Buxton